Bortezomib is the 26S proteasome in mammalian cells and reversible inhibitor of chymotrypsin-like activity, treatment of relapsed or refractory advanced non-small cell lung cancer (NSCLC) and effective.

June 21, 2017

prudect name : Bortezomib is the 26S proteasome in mammalian cells and reversible inhibitor of chymotrypsin-like activity, treatment of relapsed or refractory advanced non-small cell lung cancer (NSCLC) and effective.
Bortezomib (Velcade)

Synonyms: Bortezomib (Velcade)CAS NO: 179324-69-7Molecular Formula: C₁₉H₂₅BN₄O₄Molecular Weight: 384.24Purity: 98% minSolubility: In DMSOStorage: −20°C 2 years

LGK 974 References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/18504447